Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a conference call.
Savient Pharmaceuticals launched Krystexxa, an orphan drug for chronic gout, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers.
Health Union, an online health information and social media company, announced the launch of its first website –Migraine.com–intended to foster “interactions about health conditions between and among patients, caregivers, professionals and providers.”
Roche maintained DTC spending on Boniva, while competitors cut back
Sally Field’s winsome smile may have helped to curb declining sales of Roche’s Boniva in 2010, but it didn’t carry the drug past Warner Chilcott’s Actonel, despite a substantially higher DTC spend.
Savient focuses on reimbursement for Krystexxa launch
Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.
Sunovion targets 22,000 psychiatrists with Latuda reps
Sunovion Pharmaceuticals is targeting 22,000 psychiatrists in the US, with a sales force of 336 reps, in support of Latuda, an atypical antipsychotic for the treatment of schizophrenia.
Progenics Pharmaceuticals announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation (OIC), to Salix, beginning in April.
Epilepsy.com expands app to Android, eyes sponsorship
Epilepsy.com launched “My Epilepsy Diary” for Android mobile phone users, an extension of its Epilepsy Therapy Project Clinical Organizer suite of health tools for consumers.
GlaxoSmithKline and Human Genome Sciences launched a patient community for lupus sufferers and their friends and family, in anticipation of an FDA decision on Benlysta in March.
Sanofi Pasteur, the vaccines division of Sanofi-Aventis, tapped New York Knicks guard Chauncey Billups as its 2011 spokesperson for Vaccines for Teens, an ongoing educational and awareness campaign.